Kaken Pharmaceutical Co., Ltd.

31
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3207000005
JPY
3,940.00
3922.3 (22164.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
94,035.00
72,044.00
72,984.00
76,034.00
74,979.00
89,234.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
94,035.00
72,044.00
72,984.00
76,034.00
74,979.00
89,234.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
28.00
17.00
17.00
17.00
17.00
17.00
General and Administration Expenses
18,501.00
16,165.00
15,476.00
15,833.00
16,155.00
17,320.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
72,999.00
62,530.00
64,984.00
58,969.00
57,191.00
62,722.00
Operating Profit (PBDIT) excl Other Income
21,036.00
9,514.00
8,000.00
17,065.00
17,788.00
26,512.00
Other Income
455.00
321.00
699.00
601.00
890.00
410.00
Operating Profit (PBDIT)
24,045.00
12,588.00
11,267.00
20,147.00
20,996.00
29,683.00
Interest
28.00
17.00
17.00
17.00
17.00
17.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
2,554.00
2,753.00
2,568.00
2,481.00
2,318.00
2,761.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
19,435.00
9,796.00
6,817.00
13,885.00
18,657.00
26,592.00
Provision for Tax
5,490.00
1,770.00
1,377.00
4,336.00
5,252.00
7,222.00
Profit After Tax
13,945.00
8,025.00
5,440.00
9,549.00
13,405.00
19,370.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
365.42
212.66
144.79
251.44
347.37
494.89
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 30.52% vs -1.29% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 121.11% vs 18.93% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 64.71% vs 0.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 73.77% vs 47.52% in Mar 2024

Compare Profit and Loss Results of Kaken Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
94,035.00
33,072.00
60,963.00
184.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
94,035.00
33,072.00
60,963.00
184.33%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
28.00
155.00
-127.00
-81.94%
General and Administration Expenses
18,501.00
12,958.00
5,543.00
42.78%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
72,999.00
39,913.00
33,086.00
82.90%
Operating Profit (PBDIT) excl Other Income
21,036.00
-6,841.00
27,877.00
407.50%
Other Income
455.00
-482.00
937.00
194.40%
Operating Profit (PBDIT)
24,045.00
-3,949.00
27,994.00
708.89%
Interest
28.00
155.00
-127.00
-81.94%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
2,554.00
3,374.00
-820.00
-24.30%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
19,435.00
-6,414.00
25,849.00
403.01%
Provision for Tax
5,490.00
-1,718.00
7,208.00
419.56%
Profit After Tax
13,945.00
-4,758.00
18,703.00
393.09%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
365.4153
-38.4331
403.85
1,050.78%
Profit And Loss - Net Sales
Net Sales 94,035.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 30.52% vs -1.29% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21,036.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 121.11% vs 18.93% in Mar 2024

Profit And Loss - Interest
Interest 28.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 64.71% vs 0.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13,945.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 73.77% vs 47.52% in Mar 2024